WenXing Fan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
WenXing Fan has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
ChangYan Li
Department of Nephrology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province 650032, China
9 shared publicationsLe Zhang
Institute for Integrative Genome Biology, University of California Riverside, Riverside, CA 92521, United States
9 shared publicationsLuYao Shi
9 shared publicationsTao Liu
Organ Transplantation Center, First Affiliated Hospital of Kunming Medical University, Kunming, China
6 shared publicationsTao Wei
Department of Library, Kunming Medical University
6 shared publicationsFang Liu
Department of Nephrology, West China Hospital, Sichuan University, Chengdu, China
5 shared publications
Latest Publications
- Open Access
- 11 October 2026
- Published by Springer Nature in Diabetology & Metabolic Syndrome
Data-driven clinical phenotypes of diabetic kidney disease and their association with disease progression: a real-world cohort study
- 11 October 2026
- Published by Springer Nature in Diabetology & Metabolic Syndrome
Open AccessData-driven clinical phenotypes of diabetic kidney disease and their association with disease progression: a real-world cohort study
- Open Access
- 1 August 2026
- Published by KEAI Publishing in Genes & Diseases
Endothelin receptor antagonists in kidney disease
- 1 August 2026
- Published by KEAI Publishing in Genes & Diseases
Open AccessEndothelin receptor antagonists in kidney disease
- Open Access
- 11 April 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 316, 120136
Exploring the mechanisms of diethyl phthalate-induced diabetic nephropathy through integrated network toxicology, machine learning, and experimental validation
- 11 April 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 316, 120136
Open AccessExploring the mechanisms of diethyl phthalate-induced diabetic nephropathy through integrated network toxicology, machine learning, and experimental validation
- Open Access
- 7 March 2026
- Published by Elsevier in Asian Journal of Surgery
- Vol. 49 (11) , 5590-5592
Clinical trial landscape and bibliometric analysis of stem cell therapy in kidney transplantation
- 7 March 2026
- Published by Elsevier in Asian Journal of Surgery
- Vol. 49 (11) , 5590-5592
Open AccessClinical trial landscape and bibliometric analysis of stem cell therapy in kidney transplantation
- Open Access
- 11 December 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 8616-8619
Global clinical trial landscape of stem cell therapy for renal diseases: a 2008–2025 systematic analysis
- 11 December 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 8616-8619
Open AccessGlobal clinical trial landscape of stem cell therapy for renal diseases: a 2008–2025 systematic analysis
- Open Access
- 5 December 2025
- Published by Springer Nature in Research Square
Hyperuricemia and Diabetic Kidney Disease: A Mechanistic Exploration and Clinical Translation Study Based on Multi-Omics Integration and Real-World Evidence
Background Diabetic kidney disease (DKD), a severe microvascular complication of diabetes. Emerging evidence implicates hyperuricemia (HUA) as a critical yet underexplored contributor to DKD pathogenesis. Methods This study integrates cross-sectional data from the National Health and Nutrition Examination Survey (NHANES), transcriptomic analysis from the Gene Expression Omnibus (GEO) database, and single-center real-world longitudinal cohort data. Using multivariate regression models, machine learning algorithms, differential gene expression analysis, and the individual slope method, we systematically investigated the association between HUA and DKD and its underlying mechanisms. Results Among 5,766 diabetic patients from NHANES, the prevalence of HUA was 38.7% in the DKD group. After multivariate adjustment, HUA independently increased the risk of DKD. Real-world data analysis of diabetic patients revealed the prevalence of HUA was 37.6% ,and a significant negative correlation between baseline serum uric acid levels and the annual estimated glomerular filtration rate (eGFR) decline rate. Patients with HUA had an increased risk of rapid renal function decline. Transcriptomic analysis identified eight uric acid metabolism-related differentially expressed genes (DEGs). To assess clinical relevance, we analysed correlations between urate-related genes and DKD traits via Nephroseq v5. Our findings suggest that HUA may accelerate DKD progression via multi-aspect. Conclusion Hyperuricemia accelerates DKD progression through multiple molecular mechanisms. Personalized uric acid management strategies based on real-world evidence hold significant clinical importance.
- 5 December 2025
- Published by Springer Nature in Research Square
Open AccessHyperuricemia and Diabetic Kidney Disease: A Mechanistic Exploration and Clinical Translation Study Based on Multi-Omics Integration and Real-World Evidence
Background Diabetic kidney disease (DKD), a severe microvascular complication of diabetes. Emerging evidence implicates hyperuricemia (HUA) as a critical yet underexplored contributor to DKD pathogenesis. Methods This study integrates cross-sectional data from the National Health and Nutrition Examination Survey (NHANES), transcriptomic analysis from the Gene Expression Omnibus (GEO) database, and single-center real-world longitudinal cohort data. Using multivariate regression models, machine learning algorithms, differential gene expression analysis, and the individual slope method, we systematically investigated the association between HUA and DKD and its underlying mechanisms. Results Among 5,766 diabetic patients from NHANES, the prevalence of HUA was 38.7% in the DKD group. After multivariate adjustment, HUA independently increased the risk of DKD. Real-world data analysis of diabetic patients revealed the prevalence of HUA was 37.6% ,and a significant negative correlation between baseline serum uric acid levels and the annual estimated glomerular filtration rate (eGFR) decline rate. Patients with HUA had an increased risk of rapid renal function decline. Transcriptomic analysis identified eight uric acid metabolism-related differentially expressed genes (DEGs). To assess clinical relevance, we analysed correlations between urate-related genes and DKD traits via Nephroseq v5. Our findings suggest that HUA may accelerate DKD progression via multi-aspect. Conclusion Hyperuricemia accelerates DKD progression through multiple molecular mechanisms. Personalized uric acid management strategies based on real-world evidence hold significant clinical importance.
- 20 November 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (12) , e180
Comment on Samovski et al. Effect of Marked Weight Loss on Adipose Tissue Biology in People With Obesity and Type 2 Diabetes. Diabetes Care 2025;48:1342–1351
- 20 November 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (12) , e180
Comment on Samovski et al. Effect of Marked Weight Loss on Adipose Tissue Biology in People With Obesity and Type 2 Diabetes. Diabetes Care 2025;48:1342–1351
- Open Access
- 11 October 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 49 (3) , 1861-1862
Application of the “Hand-as-Foot” teaching method in femoral vein catheterization
- 11 October 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 49 (3) , 1861-1862
Open AccessApplication of the “Hand-as-Foot” teaching method in femoral vein catheterization
- Open Access
- 15 July 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2534524
Regarding: nailfold capillary abnormalities as indicators of diabetic nephropathy progression: a cross-sectional study in type 2 diabetes
- 15 July 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2534524
Open AccessRegarding: nailfold capillary abnormalities as indicators of diabetic nephropathy progression: a cross-sectional study in type 2 diabetes